Article
GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS.
Revista do Instituto de Medicina Tropical de Sao Paulo - 8 Dec 2016
Ramzy Iman, Elgarem Hassan, Hamza Iman, Ghaith Doaa, Elbaz Tamer, Elhosary Waleed, Mostafa Gehan, Elzahry Mohammad A Mohey Eldin
Abstract excerpt
INTRODUCTION:: Several genetic mutations affect the first-line triple therapy for Helicobacter pylori. We aimed to study the most common genetic mutations affecting the metronidazole and clarithromycin therapy for H. pylori-infected Egyptian patients. PATIENTS AND METHODS:: In our study, we included 100 successive dyspeptic patients scheduled for diagnosis through upper gastroscopy at Cairo's University Hospital,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.